Skip to main content

Table 7 TreeBagger model to separate stage I lung adenocarcinoma from those with non-inflammatory benign lung disease on 21 samples for validation

From: Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung

Signature vs. Benign
Specificity0.67Benign42Predicted
Sensitivity0.93Tumor114outcome
PPV0.88 True outcome 
NPV0.80    
Accuracy0.86    
  1. Benign: the samples with non-inflammatory conditions: LAC Stage 1, PPV Positive predictive value, NPV Negative predictive value